FDA Approved: DAURISMO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for DAURISMO (glasdegib) submitted by Pfizer Laboratories Div Pfizer Inc. The action relates to updates to the drug'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Daurismo (glasdegib)

Snippet

SUPPL AP for DAURISMO (GLASDEGIB)